E-mail this page Printer Friendly Version RSS E-mail Alerts View contacts Download Financial Tear Sheet 

Investor Relations

DGX (Common Stock)
ExchangeNYSE (US Dollar)
Change (%) Stock is Up 1.26 (2.03%)
Intraday High$63.25
Intraday Low$62.14
Data as of 08/29/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Headlines More >
Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study
Testing for the protein 14-3-3eta may improve the diagnosis of RA, including in early stages when treatment is most likely to improve outcomes MADISON, N.J., Aug. 27, 2014 /PRNewswire/ -- A novel biomarker for rheumatoid arthritis (RA) has significant potential to help physicians better identify early-stage disease, when treatment can often arrest further disease progression and disability, according to a new study in The Journal of Rheumatology. Researchers from Quest Diagnostics (NYS... 
Quest Diagnostics Declares Quarterly Cash Dividend
MADISON, N.J., Aug. 15, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.33 per share, payable on October 22, 2014 to shareholders of record of Quest Diagnostics common stock on October 7, 2014. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic information services needed to make better healthcare de... 
Quest Diagnostics Reports Second Quarter 2014 Financial Results
MADISON, N.J., July 24, 2014 /PRNewswire/ -- Revenues from continuing operations of $1.9 billion, up 4.8% versus prior year Adjusted diluted EPS from continuing operations of $1.08, up 1.9% versus  prior year Reported diluted EPS from continuing operations of $0.92, 7% below prior year Cash from operations of $280 million, up 34% versus prior year Full year 2014 revenues now expected to be up 2.5% to 3.5%, versus up 2% to 4% previously Full year 2014 adjusted diluted EPS range na... 
Quest Diagnostics Adds Vicky Gregg to Board of Directors
MADISON, N.J., July 23, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Vicky Gregg to serve as a director, effective immediately, expanding the Board to 10 members. Ms. Gregg served as the Chief Executive Officer of Chattanooga-based Blue Cross Blue Shield of Tennessee from 2003 through December 2012. Prior to being elected CEO, she served in a number of other leaders... 
Form 8-K
Board Determines That it is Advisable to Eliminate Supermajority Voting Requirements in Certificate of Incorporation08/28/13
Upcoming EventsMore >
Q3 2014 Quest Diagnostics Earnings Release
Q3 2014 Quest Diagnostics Earnings Conference Call
Contact Us:
Dan Haemmerle
Executive Director Investor Relations

Company Calendar
September 2014?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
52 Week High

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.